Clinical Trial Update: High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-dose chemotherapy for patients with poor-prognosis relapsed germ-cell tumors (testicular cancer) has completed enrollment and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Testicular Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Testicular Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-08-26